ARCHIVES

Pazdur: Registration Trials Run By Groups Need Same Rigor As Industry Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

SEC Notifies ImClone It May Bring Action Against Company

June 21, 2002

Triple-Negative Breast Cancer Increases With Number of Births

March 25, 2011

Niederhuber says his job is easy, but times are hard: NCI may need to cut up to $150 million.

December 9, 2005

Obituary: Edwin Fisher, NSABP Pathologist.

April 4, 2008

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

September 26, 2014

(8-page issue)

October 4, 2002